BIT TRADE GLOBALPUBLIC DOCUMENTATION
NIKI, BTDU, DataChips and ENTITY

Research technologies

Public information edition 0.1 · 20 October 2026 · Blackmore Technology Group Limited
Document status: Public explanatory draft. Engineering and legal status must be independently verified before relying on any operating or investment claim. No securities are offered here.

The research and knowledge stack

The BTG programme uses several distinct technologies. Their proposed roles are complementary rather than interchangeable.

NIKI — autonomous research

NIKI CGSI-SI is intended to generate technical ideas and executable approaches, test them, identify limitations and attempt repairs. Its results need reproducible evidence and independent review. Technical outputs are not automatically safe to deploy or commercially valuable.

DataChips, circuits and Circuit Genomes

A DataChip packages a typed, reusable capability with declared inputs, outputs, constraints and test evidence. A circuit combines capabilities into a workflow. A Circuit Genome records a versioned assembly that could be reconstructed and independently qualified. BTG's design permits conventional programming as well as visual composition.

BTDU — knowledge capital

The Blackmore Technology Data Universe is designed around one authoritative payload, unlimited semantic views. That principle is intended to prevent duplicated or contradictory sources while enabling controlled indexing, references and reconstruction. It does not itself prove superior storage economics or replace a trained language model.

ENTITY and governed rights

ENTITY records identity, origin, attribution, permissions and signed evidence. ADAM's proposed role is to enforce production policy and authorized state changes. A verified digital signature confirms the integrity and signer of a record—not the truth of every assertion or legal ownership of the underlying subject.

Where evidence is required

Reproducible benchmarks, independent execution, failed-case retention, software supply-chain controls, compatibility tests, rights review and economic evidence must accompany any production or commercial claim. Internal test totals should be named and scoped, not described as universal certification.